Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization

Increased dietary consumption of docosahexaenoic acid (DHA) is associated with decreased risk for Alzheimer’s disease (AD). These effects have been postulated to arise from DHA’s pleiotropic effects on AD pathophysiology, including its effects on β-amyloid (Aβ) production, aggregation, and toxicity....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurobiol Dis
Main Authors: Teng, Edmond, Taylor, Karen, Bilousova, Tina, Weiland, David, Pham, Thaidan, Zuo, Xiaohong, Yang, Fusheng, Chen, Ping-Ping, Glabe, Charles G., Takacs, Alison, Hoffman, Dennis R., Frautschy, Sally A., Cole, Gregory M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4641021/
https://ncbi.nlm.nih.gov/pubmed/26369878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2015.09.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados